CG Oncology's Phase 3 Study Highlights Potential in Bladder Cancer TreatmentRelated Stocks: CGON,...
CG Oncology, Inc. (NASDAQ:CGON) is one of the 13 Best Pharma Stocks to Buy According to Wall Street ...
Wall Street Zen raised CG Oncology from a "sell" rating to a "hold" rating in a research report on F...
Shares of CG Oncology, Inc. (NASDAQ:CGON – Get Free Report) have earned an average recommendation of...